AO1

Cards (11)

  • What is family therapy
    -is a range of interventions aimed at the family
  • What does the The National Institute for Health and Care Excellence (NICE) recommend
    -that family therapy should be offered to all individuals diagnosed with schizophrenia (SZ) who are in contact with or live with family members
    -They also state that such interventions should be a priority where there are persistent symptoms or a high risk of relapse.
  • How long is family therapy offered
    -for a period of three to twelve months with at least ten sessions; it is aimed at reducing high levels of expressed emotion (EE) as this has been shown to increase the likelihood of a relapse
    -Garety et al (2008) estimates the relapse rate for an individual who receives family therapy as 25% compared to 50% for those who receive standard care (medication only) alone.
  • One key feature of FT is psycho-education. What is that?
    -It aims to help individuals and their families to understand and better able to deal with SZ
  • Another key feature is reducing expressions of
    -anger and guilt by family members.
  • Another feature is maintaining
    -reasonable expectations among family members for patient performance.
  • Another feature is encouraging relatives
    -to set limits whilst maintaining some degree of separation when needed.
  • Pharoah (2010) reviewed 53 studies published between
    -2002 and 2010 to investigate the effectiveness of family therapy
    -Studies were chosen in Europe, Asia and North America and they compared outcomes to standard care.
  • Researchers concentrated
    -on studies that were randomised controlled trials (RCTs).
    -It was found that in terms of mental health results were mixed, some studies reported an improvement of those receiving family therapy and some did not.
  • The use of family therapy increased
    -patient’s compliance with medication. Family therapy did not have much of an effect on concrete outcomes such as living independently or employment.
  • There was a reduction
    -in the risk of relapse for those receiving family therapy and a reduction in the readmission of hospitalisation during treatment and the following 24 months afterwards.